Lumason and Cardiac arrest - a phase IV clinical study of FDA data

Summary:

Cardiac arrest is reported as a side effect among people who take Lumason (sulfur hexafluoride lipid-type a microspheres), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Anaphylaxis.

The phase IV clinical study analyzes which people have Cardiac arrest when taking Lumason. It is created by eHealthMe based on reports of 935 people who have side effects when taking Lumason from the FDA, and is updated regularly.

What is Lumason?

Lumason has active ingredients of sulfur hexafluoride lipid-type a microspheres. eHealthMe is studying from 935 Lumason users. Check the latest studies of Lumason.

What is Cardiac arrest?

Cardiac arrest is found to be associated with 2,233 drugs and 2,512 conditions by eHealthMe. Check the latest studies of Cardiac arrest.

On Jul, 21, 2026

935 people reported to have side effects when taking Lumason.
Among them, 59 people (6.31%) have Cardiac arrest.

Among these 59 people:

How long have people been on Lumason when they have Cardiac arrest? *

What is the gender of people who have Cardiac arrest when taking Lumason? *

female: 37.29 %
male: 62.71 %

What is the age of people who have Cardiac arrest when taking Lumason? *

What are other drugs people take besides Lumason? *

What are other side effects people have besides Cardiac arrest? *

Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 15 people, 25.42%
Unresponsive To Stimuli: 9 people, 15.25%
Dyspnea (difficult or laboured breathing): 7 people, 11.86%
Pulseless Electrical Activity: 6 people, 10.17%
Nausea (feeling of having an urge to vomit): 5 people, 8.47%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 4 people, 6.78%
Pulse Absent: 4 people, 6.78%
Hypotension (abnormally low blood pressure): 4 people, 6.78%
Dizziness: 4 people, 6.78%
Skin Discoloration - Bluish (bluish colour of skin): 4 people, 6.78%

What are the existing conditions these people have? *

Sedation: 1 person, 1.69%
Pericarditis (inflammation of the pericardium): 1 person, 1.69%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 1.69%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 1.69%

* Approximation only. Some reports may have incomplete information.

Do you take Lumason and have Cardiac arrest?

- Check whether Cardiac arrest is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lumason:

Lumason (935 reports)

Cardiac arrest treatments and more:

Cardiac arrest (101,931 reports)

How severe was Cardiac arrest and when was it recovered:

Cardiac arrest in Lumason

Expand to all the drugs that have ingredients of sulfur hexafluoride lipid-type a microspheres:

Cardiac arrest and drugs with ingredients of sulfur hexafluoride lipid-type a microspheres

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lumason:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac arrest:

Cardiac arrest (2,234 drugs)

Browse all the conditions that are associated with Cardiac arrest:

Cardiac arrest (2,512 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfur hexafluoride lipid-type a microspheres (the active ingredients of Lumason) and Lumason (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.